Browsing by Author Lars Rombo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
18-Sep-2015Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataElizabeth A. Ashley; Francesca Aweeka; Karen I. Barnes; Quique Bassat; Steffen Borrmann; Prabin Dahal; Timothy M.E. Davis; Mey Bouth Denis; Abdoulaye A. Djimde; Jean François Faucher; Blaise Genton; Philippe J. Guérin; Kamal Hamed; Eva Maria Hodel; Liusheng Huang; Vincent Jullien; Harin A. Karunajeewa; Jean René Kiechel; Poul Erik Kofoed; Gilbert Lefèvre; Niklas Lindegardh Lindegardh; Andreas Mårtensson; Mayfong Mayxay; Rose Mcgready; Clarissa Moreira; Paul N. Newton; Billy E. Ngasala; Francois Nosten; Christian Nsanzabana; Sunil Parikh; Patrice Piola; Ric N. Price; Pascal Ringwald; Lars Rombo; Birgit Schramm; Carol Hopkins Sibley; Kasia Stepniewska; Joel Tarning; Johan Ursing; Michele Van Vugt; Nicholas J. White; Lesley J. Workman; Philippe Deloron; Kevin Marsh; Shoklo Malaria Research Unit; Mahidol University; University of California, San Francisco; WorldWide Antimalarial Resistance Network (WWARN); University of Cape Town; Instituto de Salud Global de Barcelona; Centro de Investigação em Saúde de Manhiça (CISM); Wellcome Trust Research Laboratories Nairobi; Universitat Tubingen; Nuffield Department of Clinical Medicine; University of Western Australia; IRD Institut de Recherche pour le Developpement; Universite Paris Descartes; National Center for Parasitology; Organisation Mondiale de la Sante; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; Hopital Jean Minjoz; Swiss Tropical and Public Health Institute (Swiss TPH); Centre Hospitalier Universitaire Vaudois; Novartis Pharmaceuticals Corporation; Liverpool School of Tropical Medicine; Drugs for Neglected Diseases Initiative; Syddansk Universitet; Kolding Sygehus; Novartis International AG; Kenya Medical Research Institute; Karolinska Institutet; Wellcome Trust; Muhimbili University of Health and Allied Sciences; Yale Schools of Public Health and Medicine; Department of Clinical Pharmacology; Institut Pasteur de Madagascar; Menzies School of Health Research; Uppsala Universitet; Epicentre; University of Washington, Seattle; University of Amsterdam
23-Jan-2014Chloroquine is grossly under dosed in young children with malaria: Implications for drug resistanceJohan Ursing; Staffan Eksborg; Lars Rombo; Yngve Bergqvist; Daniel Blessborn; Amabelia Rodrigues; Poul Erik Kofoed; Indepth Network; Karolinska University Hospital; Karolinska Institutet; Uppsala Universitet; Hogskolan Dalarna; Mahidol University; Nuffield Department of Clinical Medicine; Kolding Sygehus
17-Dec-2013Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up studyElina O. Erra; Helena Hervius Askling; Sutee Yoksan; Lars Rombo; Jukka Riutta; Sirkka Vene; Lars Lindquist; Olli Vapalahti; Anu Kantele; University of Helsinki Haartman Institute; Helsinki University Hospital; Karolinska Institutet; Mahidol University; Sormland County Council; Medical Centre Aava; Swedish Institute for Communicable Disease Control; Helsingin Yliopisto
15-Jan-2013Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypesElina O. Erra; Helena Hervius Askling; Sutee Yoksan; Lars Rombo; Jukka Riutta; Sirkka Vene; Lars Lindquist; Olli Vapalahti; Anu Kantele; University of Helsinki Haartman Institute; Helsinki University Hospital; Karolinska Institutet; Mahidol University; Sörmland County Council; Medical Centre Aava; Swedish Institute for Communicable Disease Control; Department of Veterinary Biosciences; Helsingin Yliopisto
1-Jan-2014Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: Parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan; Nahla B. Gadalla; Kasia Stepniewska; Prabin Dahal; Christian Nsanzabana; Clarissa Moriera; Ric N. Price; Andreas Ma˚rtensson; Philip J. Rosenthal; Grant Dorsey; Colin J. Sutherland; Philippe Guérin; Timothy M.E. Davis; Didier Ménard; Ishag Adam; George Ademowo; Cesar Arze; Frederick N. Baliraine; Nicole Berens-Riha; Anders Björkman; Steffen Borrmann; Francesco Checchi; Meghna Desai; Mehul Dhorda; Abdoulaye A. Djimdé; Badria B. El-Sayed; Teferi Eshetu; Frederick Eyase; Catherine Falade; Jean Franc¸ois Faucher; Gabrielle Fröberg; Anastasia Grivoyannis; Sally Hamour; Sandrine Houzé; Jacob Johnson; Erasmus Kamugisha; Simon Kariuki; Jean René Kiechel; Fred Kironde; Poul Erik Kofoed; Jacques LeBras; Maja Malmberg; Leah Mwai; Billy Ngasala; Francois Nosten; Samuel L. Nsobya; Alexis Nzila; Mary Oguike; Sabina Dahlström Otienoburu; Bernhards Ogutu; Jean Bosco Ouédraogo; Patrice Piola; Lars Rombo; Birgit Schramm; A. Fabrice Somé; Julie Thwing; Johan Ursing; Rina P.M. Wong; Ahmed Zeynudin; Issaka Zongo; Christopher V. Plowe; Carol Hopkins Sibley; University of Maryland School of Medicine; National Institute of Allergy and Infectious Diseases; Tropical Medicine Research Institute Sudan; Nuffield Department of Clinical Medicine; Menzies School of Health Research; Karolinska Institutet; University of California, San Francisco; London School of Hygiene & Tropical Medicine; University of Western Australia Faculty of Medicine and Dentistry; Institut Pasteur du Cambodge; University of Khartoum Faculty of Medicine; University of Ibadan; LeTourneau University; Ludwig-Maximilians-Universitat Munchen; Sveriges lantbruksuniversitet; Wellcome Trust Research Laboratories Nairobi; Magdeburg School of Medicine; Save the Children Fund; Centers for Disease Control and Prevention; Epicentre; University of Sciences; Jimma University; Kenya Medical Research Institute; Besançon University Medical Center; IRD Institut de Recherche pour le Developpement; University of Washington, Seattle; UCL; Hopital Bichat-Claude-Bernard AP-HP; Universite Paris Descartes; Catholic University of Health and Allied Sciences-Bugando; Drugs for Neglected Diseases Initiative; Makerere University; St. Augustine International University; Projecto de Saúde de Bandim; Kolding Sygehus; The University of British Columbia; Muhimbili University of Health and Allied Sciences; Mahidol University; King Fahd University of Petroleum and Minerals; -Bernard Hospital; Centre MURAZ; Institut Pasteur de Madagascar
1-Sep-2012A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccinesElina O. Erra; Helena Hervius Askling; Lars Rombo; Jukka Riutta; Sirkka Vene; Sutee Yoksan; Lars Lindquist; Sari H. Pakkanen; Eili Huhtamo; Olli Vapalahti; Anu Kantele; University of Helsinki Haartman Institute; Helsinki University Hospital; Karolinska Institutet; Sormland County Council; Travel Clinic; Swedish Institute for Communicable Disease Control; Mahidol University; Helsingin Yliopisto
Jun-2012A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.Elina O. Erra; Helena Hervius Askling; Lars Rombo; Jukka Riutta; Sirkka Vene; Sutee Yoksan; Lars Lindquist; Pakkanen, Sari H.; Eili Huhtamo; Olli Vapalahti; Anu Kantele; Mahidol University. Faculty of Medicine. Haartman Institute; Mahidol University. Institute of Molecular Bioscience